SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-19-008511
Filing Date
2019-07-25
Accepted
2019-07-25 16:08:56
Documents
3
Effectiveness Date
2019-07-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A vtgndefa14a_sep052019.htm DEFA14A 21721
2 IMAGE proxy000.jpg GRAPHIC 107146
3 IMAGE proxy001.jpg GRAPHIC 74630
  Complete submission text file 0001654954-19-008511.txt   273376
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-37761 | Film No.: 19974535
SIC: 2834 Pharmaceutical Preparations